Primary Children's Medical Center/University of Utah
Clinical research site in Salt Lake City, Utah · 50 N MEDICAL DR, SALT LAKE CITY, UT 84132-0001 · (801) 581-2121
As of September 2026, 43 paid clinical trials are recruiting at Primary Children's Medical Center/University of Utah in Salt Lake City, Utah. Active studies at this site cover conditions such as Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma and Advanced Gastroesophageal Junction Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Primary Children's Medical Center/University of Utah (43)
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
Patient Retrospective Outcomes (PRO)
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
QTX3034 in Patients With KRAS G12D Mutation
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
US National OCS Liver Perfusion (OLP) Registry
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Mucopolysaccharidosis VII Disease Monitoring Program
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Tocilizumab in Lung Transplantation
Platelet Rich Plasma for Musculoskeletal Conditions
Belatacept in Heart Transplantation
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
Showing the 40 most relevant of 43 recruiting trials at this site. Browse all with filters →
Get new-trial alerts for Primary Children's Medical Center/University of Utah
We'll email you whenever a new clinical trial starts recruiting at this research site in Salt Lake City, UT. Unsubscribe anytime.
More research sites in Salt Lake City
- University of Utah (211 trials)
- Huntsman Cancer Institute/University of Utah (73 trials)
- Primary Children's Hospital (60 trials)
- Huntsman Cancer Institute (59 trials)
- Huntsman Cancer Institute, University of Utah (34 trials)
- University of Utah Health (28 trials)
- Huntsman Cancer Institute at University of Utah (22 trials)
- University of Utah Hospital (21 trials)
- VA Salt Lake City Health Care System, Salt Lake City, UT (17 trials)
- University of Utah Sugarhouse Health Center (16 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Salt Lake City, UT · Utah clinical trials